Article metrics

Download PDFPDF

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al
Free

 

Online download statistics by month:

Online download statistics by month: August 2020 to May 2022

AbstractFullPdf
Aug 2020474454175
Sep 202039835084
Oct 202011211659
Nov 2020969760
Dec 2020575731
Jan 2021585828
Feb 2021555533
Mar 2021505029
Apr 2021707039
May 2021898924
Jun 2021343411
Jul 2021514727
Aug 2021464614
Sep 2021464717
Oct 2021575146
Nov 2021464419
Dec 2021949413
Jan 2022625819
Feb 2022424310
Mar 202251478
Apr 202234368
May 2022383617
Total20601979771